Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.63B |
| 2 |
Qualcomm
QCOM
|
+$305M |
| 3 |
Marathon Petroleum
MPC
|
+$253M |
| 4 |
Cigna
CI
|
+$248M |
| 5 |
Harley-Davidson
HOG
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$1.49B |
| 2 |
CA
CA, Inc.
CA
|
+$745M |
| 3 |
Apple
AAPL
|
+$728M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$575M |
| 5 |
AET
Aetna Inc
AET
|
+$537M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.07% |
| 2 | Healthcare | 14.29% |
| 3 | Financials | 13.72% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
ICU Medical
ICUI
$4.58B
| $47.4M | 0.01% |
206,412
+14,456
| +8% | +$3.56M |
|
|
CCMP
927
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $47.3M | 0.01% |
496,469
+42,820
| +9% | +$4.2M |
|
928
Nu Skin
NUS
$236M
| $47.3M | 0.01% |
770,962
-49,254
| -6% | -$3.32M |
|
929
Emergent Biosolutions
EBS
$233M
| $47.3M | 0.01% |
797,594
-54,246
| -6% | -$3.5M |
|
930
Manulife Financial
MFC
$72.6B
| $47.2M | 0.01% |
3,328,486
+33,509
| +1% | +$531K |
|
|
RDS.B
931
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $47.1M | 0.01% |
786,350
-46,028
| -6% | -$2.94M |
|
932
Fidelity National Financial
FNF
$12.8B
| $47M | 0.01% |
1,555,421
+81,869
| +6% | +$2.64M |
|
933
Yum China
YUMC
$16.4B
| $46.9M | 0.01% |
1,399,446
-89,213
| -6% | -$3.06M |
|
934
iShares Morningstar Value ETF
ILCV
$1.36B
| $46.9M | 0.01% |
+972,832
| New | +$50.1M |
|
935
Compass Minerals
CMP
$1.12B
| $46.8M | 0.01% |
1,123,458
+207,072
| +23% | +$10.9M |
|
936
TD Synnex
SNX
$20.4B
| $46.8M | 0.01% |
1,157,972
+349,726
| +43% | +$13.8M |
|
|
VSM
937
DELISTED
Versum Materials, Inc.
VSM
| $46.6M | 0.01% |
1,682,633
+40,216
| +2% | +$1.27M |
|
938
Liberty Media Series C
FWONK
$26B
| $46.6M | 0.01% |
1,571,258
-258,548
| -14% | -$8.04M |
|
939
Nektar Therapeutics
NKTR
$2.57B
| $46.6M | 0.01% |
94,580
+1,178
| +1% | +$711K |
|
|
UN
940
DELISTED
Unilever NV New York Registry Shares
UN
| $46.6M | 0.01% |
866,595
+57,866
| +7% | +$3.16M |
|
|
MZTI
941
The Marzetti Company
MZTI
$3.18B
| $46.6M | 0.01% |
263,560
-10,261
| -4% | -$1.75M |
|
942
ASML
ASML
$710B
| $46.5M | 0.01% |
298,567
-11,744
| -4% | -$1.99M |
|
943
Texas Capital Bancshares
TCBI
$4.38B
| $46.5M | 0.01% |
909,206
+270,663
| +42% | +$17.1M |
|
944
Viavi Solutions
VIAV
$10.6B
| $46.4M | 0.01% |
4,621,192
-5,906,184
| -56% | -$63.7M |
|
|
VRNT
945
DELISTED
Verint Systems
VRNT
| $46.4M | 0.01% |
2,154,538
+231,821
| +12% | +$5.33M |
|
946
Healthcare Realty
HR
$6.58B
| $46.4M | 0.01% |
1,834,611
+71,989
| +4% | +$1.91M |
|
|
GWR
947
DELISTED
Genesee & Wyoming Inc.
GWR
| $46.4M | 0.01% |
627,160
-12,029
| -2% | -$964K |
|
948
Urban Edge Properties
UE
$2.75B
| $46.4M | 0.01% |
2,791,445
-186,200
| -6% | -$3.67M |
|
949
Rapid7
RPD
$827M
| $46.3M | 0.01% |
1,486,628
-22,379
| -1% | -$733K |
|
|
BEAT
950
DELISTED
BioTelemetry, Inc.
BEAT
| $46.2M | 0.01% |
773,725
-47,143
| -6% | -$2.83M |
|
Similar funds
Bank of New York Mellon's Q4 2018 Portfolio in Review
As of Q4 2018, Bank of New York Mellon held 4,394 positions worth $319B, down 18% from $389B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Bank of New York Mellon withdrew a net $13.4B in Q4 2018, closing 173 positions and reducing 1,980 holdings. Its most notable exit was Praxair Inc, an estimated $1.49B position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Bank of New York Mellon opened a new position in Linde worth $1.6B.
- Bank of New York Mellon's largest Q4 2018 buy was Linde: 10,284,764 shares worth $1.6B.
- Bank of New York Mellon added most to Qualcomm in Q4 2018, an estimated $305M increase.
- Bank of New York Mellon's biggest Q4 2018 reduction was Apple, cutting an estimated $728M.
- Bank of New York Mellon fully exited Praxair Inc in Q4 2018, selling an estimated $1.49B.
- Bank of New York Mellon's ten largest holdings make up 15% of its $319B portfolio in Q4 2018.
- Bank of New York Mellon opened 150 new positions and closed 173 in Q4 2018.
- Bank of New York Mellon's portfolio value fell 18% quarter-over-quarter to $319B.
Based on Bank of New York Mellon's 13F filing for Q4 2018, filed 11 Feb 2019.